• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Health Tech

Makary
Biotech

FDA unveils plan for real-time review of clinical trial data

The FDA is testing allowing its reviewers to access information from clinical trials in real time, with AstraZeneca and Amgen already on board.
Darren Incorvaia Apr 28, 2026 1:52pm
An illustration of a white strand of DNA which lies horizontally across an image

Lilly pens $2.2B gene editing pact with Bezos-backed Profluent

Apr 28, 2026 8:40am
Merck booth at AACR 2026
Favicon Fierce Pharma

Merck goes with Google for AI push, strikes $1B enterprise deal

Apr 22, 2026 10:12am
lab artificial intelligence

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Apr 17, 2026 10:00am
light bulb think theory idea bright dull lights out

Small pools, big ideas: Rare disease community reimagines trials

Apr 17, 2026 3:00am
Narasimhan
Favicon Fierce Pharma

Novartis CEO Vas Narasimhan joins Anthropic's board

Apr 15, 2026 10:36am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings